Peterson B Z, Catterall W A
Department of Pharmacology, School of Medicine, University of Washington, Seattle 98195, USA.
J Biol Chem. 1995 Aug 4;270(31):18201-4. doi: 10.1074/jbc.270.31.18201.
The pore-forming alpha 1 subunit of L-type voltage-gated Ca2+ channels contains a Ca(2+)-binding site that is allosterically coupled to the receptor site for dihydropyridine (DHP) Ca2+ antagonists. Site-directed mutations of conserved Phe and Glu residues in the pore-lining SS1/SS2 segments greatly reduced Ca2+ enhancement of DHP binding. Substitution of Phe-1013 in the alpha 1 subunit from rabbit skeletal muscle (alpha 1S) with Gly (F1013G) as in DHP-insensitive Ca2+ channels caused a 4-fold decrease in sensitivity to Ca2+. Mutation of the Ca(2+)-binding residues Glu-1014 in domain III and Glu-1323 in domain IV to Gln (E1014Q and E1323Q) caused 11- and 35-fold decreases in sensitivity to Ca2+, respectively, as well as decreases in the maximal DHP binding affinities attained at optimal concentrations of Ca2+. DHP binding to the charge-reversal mutation, E1014K, had no sensitivity to Ca2+. Our results demonstrate that high affinity Ca2+ binding to the Glu residues in the SS1/SS2 segments of domains III and IV of alpha 1S stabilizes the DHP receptor site in its high affinity state. We propose a three-state model in which the affinity for DHPs is dependent on the presence of 0, 1, or 2 bound Ca2+ ions at sites in the pore.
L型电压门控Ca2+通道的成孔α1亚基含有一个Ca(2+)结合位点,该位点与二氢吡啶(DHP)Ca2+拮抗剂的受体位点存在变构偶联。孔内衬SS1/SS2片段中保守的苯丙氨酸(Phe)和谷氨酸(Glu)残基的定点突变极大地降低了Ca2+对DHP结合的增强作用。将兔骨骼肌α1亚基(α1S)中的Phe-1013替换为甘氨酸(F1013G),如同在对DHP不敏感的Ca2+通道中那样,导致对Ca2+的敏感性降低了4倍。将结构域III中的Ca(2+)结合残基Glu-1014和结构域IV中的Glu-1323突变为谷氨酰胺(E1014Q和E1323Q),分别导致对Ca2+的敏感性降低了11倍和35倍,同时在最佳Ca2+浓度下达到的最大DHP结合亲和力也降低了。DHP与电荷反转突变体E1014K的结合对Ca2+不敏感。我们的结果表明,α1S结构域III和IV的SS1/SS2片段中的Glu残基与高亲和力Ca2+结合,使DHP受体位点稳定在其高亲和力状态。我们提出了一个三态模型,其中对DHP的亲和力取决于孔中位点上结合的Ca2+离子的数量为0、1或2。